Caricamento...
Patisiran for advanced heart failure with hereditary transthyretin cardiac amyloidosis
We experienced a 78-year-old woman who was diagnosed with hereditary transthyretin cardiac amyloidosis and administered patisiran for advanced heart failure refractory to tafamidis. The levels of N-terminal pro B-type natriuretic peptide and left ventricular mass index decreased following the six-mo...
Salvato in:
| Pubblicato in: | J Cardiol Cases |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Japanese College of Cardiology
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8020066/ https://ncbi.nlm.nih.gov/pubmed/33841597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2021.01.007 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|